ArticleAdvanced biomedical research2025
MiR-15a-5p, c-MYB, and circHIPK3 Axis as a Potential Diagnostic and Clinicopathological-Related Network in Acute Myeloid Leukemia.
Article in Advanced biomedical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- RNA Therapeutics in Viral Infections and Cancer: Mechanisms, Challenges, and Prospects: A Review.Pharmaceutics · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Due to heterogeneity of acute myeloid leukemia (AML) in prognosis and response to treatment, understanding the pathophysiology of AML helps to find new factors as diagnostic and clinicopathological-related biomarkers and therapeutic targets. Materials and Methods: Using quantitative real-time polymerase chain reaction on AML patients, the expression of the miR15a-5p, c-MYB, and circ-HIPK3 gene network was measured, and the diagnostic performance and clinical application value of this gene network were also investigated. Results: In AML patients compared with healthy controls, the expression of mir-15a-5p and circ-HIPK3 significantly decreased, and the expression of c-MYB was significantly upregulated. Furthermore, c-MYB correlates with circ-HIPK3 positively. The areas under receiver operating characteristic curves (AUCs) of miR15a-5p, c-MYB, and circ-HIPK3 were 0.675, 0.885, and 0.762, respectively. Also, peripheral blood, as a noninvasive and cost-effective diagnostic sample, has good diagnostic value for the investigation of the mir15a-5p, c-MYB, and circ-HIPK3 genes. Finally, the change in circ-HIPK3 expression and red blood cell count showed a significant relationship. Conclusion: The results can contribute to a better pathophysiology understanding of AML, lead to the discovery of new diagnostic biomarkers, and develop treatment goals for patients. Also, the relationship between the genes and the clinicopathological characteristics of the patients helps patient monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.